You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output.
Click here to find out more.
Twitter Demographics
Mendeley readers
Attention Score in Context
Title |
Safety, activity, and molecular heterogeneity following neoadjuvant non-pegylated liposomal doxorubicin, paclitaxel, trastuzumab, and pertuzumab in HER2-positive breast cancer (Opti-HER HEART): an open-label, single-group, multicenter, phase 2 trial
|
---|---|
Published in |
BMC Medicine, January 2019
|
DOI | 10.1186/s12916-018-1233-1 |
Pubmed ID | |
Authors |
Joaquín Gavilá, Mafalda Oliveira, Tomás Pascual, Jose Perez-Garcia, Xavier Gonzàlez, Jordi Canes, Laia Paré, Isabel Calvo, Eva Ciruelos, Montserrat Muñoz, Juan A. Virizuela, Isabel Ruiz, Raquel Andrés, Antonia Perelló, Jerónimo Martínez, Serafín Morales, Mercedes Marín-Aguilera, Débora Martínez, Juan C. Quero, Antonio Llombart-Cussac, Aleix Prat |
Twitter Demographics
The data shown below were collected from the profiles of 37 tweeters who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
Country | Count | As % |
---|---|---|
Spain | 16 | 43% |
Belgium | 2 | 5% |
United Kingdom | 2 | 5% |
United States | 2 | 5% |
Ecuador | 1 | 3% |
Colombia | 1 | 3% |
Denmark | 1 | 3% |
Mexico | 1 | 3% |
Italy | 1 | 3% |
Other | 0 | 0% |
Unknown | 10 | 27% |
Demographic breakdown
Type | Count | As % |
---|---|---|
Members of the public | 24 | 65% |
Practitioners (doctors, other healthcare professionals) | 7 | 19% |
Scientists | 6 | 16% |
Mendeley readers
The data shown below were compiled from readership statistics for 71 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
Country | Count | As % |
---|---|---|
Unknown | 71 | 100% |
Demographic breakdown
Readers by professional status | Count | As % |
---|---|---|
Researcher | 9 | 13% |
Student > Bachelor | 9 | 13% |
Other | 8 | 11% |
Student > Postgraduate | 5 | 7% |
Student > Master | 5 | 7% |
Other | 15 | 21% |
Unknown | 20 | 28% |
Readers by discipline | Count | As % |
---|---|---|
Medicine and Dentistry | 19 | 27% |
Pharmacology, Toxicology and Pharmaceutical Science | 6 | 8% |
Biochemistry, Genetics and Molecular Biology | 6 | 8% |
Nursing and Health Professions | 3 | 4% |
Agricultural and Biological Sciences | 3 | 4% |
Other | 8 | 11% |
Unknown | 26 | 37% |
Attention Score in Context
This research output has an Altmetric Attention Score of 24. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 09 July 2019.
All research outputs
#1,371,915
of 23,122,481 outputs
Outputs from BMC Medicine
#956
of 3,476 outputs
Outputs of similar age
#34,590
of 438,317 outputs
Outputs of similar age from BMC Medicine
#19
of 68 outputs
Altmetric has tracked 23,122,481 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 94th percentile: it's in the top 10% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 3,476 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 43.6. This one has gotten more attention than average, scoring higher than 72% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 438,317 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 92% of its contemporaries.
We're also able to compare this research output to 68 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 72% of its contemporaries.